Skip to main content
Clinical Trials/NL-OMON39912
NL-OMON39912
Recruiting
Not Applicable

Determination of peripheral immune cell activity during treatment with either surgery or radiotherapy in patients with early stage non-small cell lung cancer. - HAMLET study

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
lung cancer
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Cytologically or histologically proven cT1\-2aN0M0 NSCLC
  • \- Patients \>\= 18 years old
  • \- Patients should be fit to undergo both treatments in accordance with institutional protocols

Exclusion Criteria

  • \- Patients with any sign of any co\-existing infectious disease or immunosuppressive treatment (inhalation steroids are permitted)
  • \- Mentally incapacitated subjects

Outcomes

Primary Outcomes

Not specified

Similar Trials